Profile

AISLING CAPITAL IS A LEADING INVESTMENT FIRM THAT INVESTS IN COMPANIES DEVELOPING AND COMMERCIALIZING IMPORTANT AND INNOVATIVE HEALTHCARE PRODUCTS, SERVICES AND TECHNOLOGIES. Aisling Capital is a leading investment firm that invests in products, technologies, and global businesses that advance health. Since 2000, Aisling Capital has raised over $1.8 billion in committed capital across four funds. Aisling Capital invests in both private and public companies utilizing a wide variety of investment structures. The Aisling Capital team’s combination of clinical, operational and financial experience allows the firm to identify, execute and realize investments across the life sciences industry. OUR STRATEGY Aisling Capital seeks to identify differentiated healthcare products, services and technologies that address unmet medical needs. Our business is to provide promising companies with meaningful capital resources and to assist them in achieving their growth objectives. We identify healthcare companies at a stage in their development where an infusion of capital and strategic assistance will significantly enhance the opportunities for success. OUR INVESTMENTS Aisling Capital makes investment decisions driven by fundamental assessment of scientific, regulatory, financial and commercial risks. Given our investment team’s broad skillset, we invest across the life sciences, including seed and venture financings of development-stage companies, small-cap publicly traded equities, structured debt and royalty deals and large-cap leveraged buyouts of profitable companies. OUR APPROACH Aisling Capital takes an active approach to investing, working closely with portfolio companies to help them become value-building enterprises with multiple opportunities for exit. Our investment professionals collaborate with management teams and contribute expertise and experience to help determine and execute strategy, identify and evaluate business opportunities and address financial issues.